11:14 AM EDT, 05/20/2024 (MT Newswires) -- Immunome ( IMNM ) said Monday it completed its purchase of antibodies and related assets from Atreca for an upfront payment of $5.5 million and a potential clinical development milestone payment of up to $7 million.
Shares of the company fell 0.5% in recent trading.
Price: 13.76, Change: -0.07, Percent Change: -0.51